Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans

Gerardo Becerra Victorio1, Lorena Michele Brennan Bourdon2, Leonel García Benavides3

  • 1Universidad Autónoma de Chiapas, Facultad de Ciencias Químicas, Chiapas, Mexico.

Abstract

Insights

Caspofungin and liposomal amphotericin B show similar effectiveness in treating experimental infective endocarditis caused by Candida albicans. Both antifungals significantly reduced fungal colonization in a rat model, offering hope for treating this serious infection.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Infective endocarditis involves heart valve lesions with extracellular matrix barriers hindering antimicrobial penetration.
  • The genus Candida is a growing cause of hospital-acquired infections.

Purpose of the Study:

  • To compare the efficacy of caspofungin and liposomal amphotericin B against Candida albicans in a rat model of infective endocarditis.

Main Methods:

  • Experimental infective endocarditis was induced in Wistar rats using Candida albicans.
  • Treatment groups included caspofungin, liposomal amphotericin B, and placebo.
  • Antifungal activity was assessed via semiquantitative culture of vegetations and histological analysis.

Main Results:

  • Untreated rats exhibited massive Candida albicans colonization in vegetations.
  • Both caspofungin and liposomal amphotericin B significantly reduced fungal colonization.
  • The reduction in colonization was comparable between the two antifungal treatments.

Conclusions:

  • Caspofungin demonstrates antifungal activity comparable to liposomal amphotericin B.
  • These findings support the use of caspofungin as a treatment option for experimental Candida albicans infective endocarditis.